ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983

Wake Forest, Norris Cotton Recognized Broder: Oncologists Need a Major Success In The 1990s

August 31, 1990